MoneyWorks4Me

Neuland Laboratories - Quaterly Results

06 Nov 2024 Evaluate
The sales for the September 2024 quarter moved down to Rs. 3108.44 millions as compared to Rs. 4177.49 millions during the year-ago period.A big decline of -64.12% was reported for the quarter ended September 2024 to Rs. 319.59  millions from Rs. 890.65 millions of corresponding previous quarter.A decline of 656.75 millions was observed in the OP in the quarter ended September 2024 from 1403.46 millions on QoQ basis.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202409 202309 % Var 202409 202309 % Var 202403 202303 % Var
Sales 3108.44 4177.49 -25.59 7504.46 7807.43 -3.88 15585.80 11911.98 30.84
Other Income 43.32 30.48 42.13 91.39 50.87 79.65 125.44 97.48 28.68
PBIDT 656.75 1403.46 -53.20 1943.08 2396.50 -18.92 4744.65 2810.56 68.82
Interest 10.63 44.33 -76.02 37.34 66.47 -43.82 139.97 130.67 7.12
PBDT 646.12 1359.13 -52.46 2112.00 2330.03 -9.36 4604.68 2679.89 71.82
Depreciation 160.73 145.08 10.79 323.52 280.94 15.16 596.99 527.76 13.12
PBT 485.39 1214.05 -60.02 1788.48 2049.09 -12.72 4007.69 2152.13 86.22
TAX 165.80 323.40 -48.73 485.50 536.20 -9.46 1011.73 520.94 94.21
Deferred Tax 43.68 9.03 383.72 57.57 12.36 365.78 15.87 17.04 -6.87
PAT 319.59 890.65 -64.12 1302.98 1512.89 -13.87 2995.96 1631.19 83.67
Equity 129.01 129.01 0.00 129.01 129.01 0.00 129.01 129.01 0.00
PBIDTM(%) 21.13 33.60 -37.11 25.89 30.70 -15.65 30.44 23.59 29.02
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..